Treatment gains observed at @-month follow-up ( @MFU ) on measures of clinical severity , general symptoms of depression and anxiety , and a measure of symptom interference in daily functioning were largely maintained @months later ( at an average of @months posttreatment ) , and any significant changes from @MFU to LTFU reflected small increases in symptoms that remained , on average , in the subclinical range .